(ecancermedicalscience) In an editorial to be published on Tuesday June 27, 2017 in the journal ecancermedicalscience, Anthony Hatswell of BresMed and University College London, explores the consequences of a British exit from the European Medicines Agency as a result of Brexit, and what this will mean for pharmaceutical regulation and future access to medicines for UK citizens.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2rX3pCz
No comments:
Post a Comment